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Aim. To study the subcellular localization of phospho-mTOR (Ser2481) in cultured cells of human cancer cell 
lines. Methods. Immunofluorescent analysis of phospho-mTOR (Ser2481) subcellular localization in cultured 
MCF-7 (human breast adenocarcinoma) and HepG2 (human liver carcinoma) cells. Results. For the first time 
phospho-mTOR (Ser2481) was detected as bright spots situated in the equatorial region of chromosomes and 
co-localized with condensed chromosomes during metaphase. Conclusions. In this study, we describe for the first 
time the co-localization of phospho-mTOR (Ser2481) and chromosomes of the metaphase plate in the MCF-7 
and HepG2 cells. Our data support the hypothesis that phospho-mTOR (Ser2481) could act as a CPP (chromo-
somal passenger protein)-like kinase, which takes part in the regulation of mitosis progression.
K e y w o r d s: mTOR, phospho-mTOR (Ser2481), mitosis, mTOR phosphorylation, metaphase.
Introduction
The mammalian target of rapamycin (mTOR) is a pro-
tein kinase involved in the regulation of cell growth and 
aging affecting numerous biosynthetic processes and 
cell metabolism [1]. Deregulation of mTOR is ob-
served in many pathologies, including cancer, meta-
bolic and neurodegenerative disorders [2, 3].
Phosphorylation is one of the main posttranslational 
modifications that regulate kinase activity [4]. Usually, 
gradual modification of several phosphorylation sites 
is needed for full activation of protein kinases. 
Phospho ry lation could also play an important role in 
the regulation of kinase subcellular localization [5, 6].
mTOR kinase has four characterized phosphory-
lation sites: Ser1261 localized at the HEAT domain 
and three other sites Thr2446, Ser2448, Ser2481 – at 
regulatory domain, which is important for the mTOR 
kinase activity [7, 8]. Phosphorylation of serine 2481 
is detected only in vertebrates and is known to be 
[an] autophosphorylation site. [9]. 
Previous studies showed that phospho-mTOR 
(Ser2481) is located at the midzone and cleavage 
furrow of the dividing cells. It was proposed that 
phospho-mTOR (Ser2481) could be a mitotic kinase 
[10]. However, the role of Ser2481 phosphorylation 
and targets of phospho-mTOR (Ser2481) during mi-
tosis are unknown.
In this study we have shown for the first time that 
phospho-mTOR (Ser2481) localized as discrete foci 
at metaphase plate during mitosis in human cell lines 
MCF-7 and HepG2. Our data support the hypothesis 
proposed earlier that phospho-mTOR (Ser 2481) 
could act as a CPP (chromosomal passenger protein)-
like kinase during mitosis [11].
Materials and Methods
Cell culture
MCF-7 and HepG2 cells were cultivated in DMEM 
culture medium supplemented with 10 % FCS, 
4 mM glutamine, 50 units/ml penicillin, 50 µg/ml 
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streptomycin, medium was changed every third day. 
For immunofluorescent analysis the cells were seed-
ed onto sterile glass coverslips and cultured for 2–3 
days in 24 well plates. 
Immunofluorescent analysis
Cultured MCF-7 or HepG2 cells were fixed with 
methanol for 10 min at room temperature. Thereafter, 
the cells were permeabilized with 0.2 % Triton 
X-100 in PBS for 10 min and incubated for 30 min at 
room temperature in 10 mM cupric sulphate and 
50 mM ammonium acetate, pH 5.0 to eliminate au-
tofluorescence. Non-specific binding was blocked 
after incubation with 10 % FCS in PBS for 30 min at 
37°C. Between incubations the cells were washed 
with PBS three times for 3 min.
Double immunofluorescent analysis was per-
formed by addition of the primary antibody mix: 
rabbit ā- phospho-mTOR (Ser2481) + mouse ā- 
Ki-67, ā -mTOR antibodies for 1 h at 37 °C in hu-
midifying chamber.
The following dilutions of antibodies were used: 
rabbit polyclonal anti-phospho-mTOR (Ser2481) 
antibody (09-343 Merck Millipore, USA) 1:100, 
anti-Ki-67 antibody 1:1000 (generated and tested in 
our laboratory [12]), mouse ā- mTOR (clone F11, 
MABS14, Merck Millipore, USA) 1:50, rabbit 
ā-mTOR (N-19, sc-1549, Santa Cruz Biotechnology, 
USA) 1:50, rabbit ā-mTOR (7C10, #2983, Cell 
Signaling Technology, USA) 1:50. 
The secondary FITC conjugated anti-mouse anti-
bodies, Texas Red conjugated anti-rabbit antibodies 
(Jackson ImmunoResearch Laboratories, Pennsyl-
va nia, USA) were applied as a mix in dilution 1:400 
for 45 min at 37°C in humidifying chamber. In some 
cases DNA was counterstained with Hoechst 33342. 
Samples were washed and embedded into Mowiol 
medium (Sigma-Aldrich, St. Louis, USA) contain-
ing 2.5 % DABCO (Sigma-Aldrich, St. Louis, USA). 
All microscopy studies were performed using 
Leica DM 1000 fluorescent microscope (Leica 
Microsystems, Wetzlar, Germany) and Zeiss LSM 
510 META microscope (Carl Zeiss Microscopy 
GmbH, Jena, Germany).
Results
Double immunofluorescent analysis was performed 
on cell lines MCF-7 and HepG2 to study the pecu-
liarities of the phospho-mTOR (Ser2481) subcellu-
lar localization. Antibody to the proliferating cell 
antigen Ki-67 was applied to visualize and distinct 
the different stages of cell cycle. 
Interphase cells showed very low level of phos-
pho-mTOR (Ser2481) fluorescence signal. In con-
trast, mitotic cells demonstrated bright staining, 
which had dramatically different subcellular local-
ization of phospho-mTOR (Ser2481) during mitosis 
progression.
Phospho-mTOR (Ser2481) was detected at the 
midbody and the cleavage furrow in the anaphase 
and telophase (Fig. 1 A, small arrow) as it was re-
ported earlier [11]. However, we observed phospho-
mTOR (Ser2481) as bright dots among the arms of 
condensed chromosomes in metaphase for the first 
time (Fig. 1 A, long arrows). Double immunofluo-
rescent analysis revealed phospho-mTOR (Ser2481) 
at the metaphase plates of HepG2 (Fig. 1 B) and 
MCF-7 (Fig. 1 C) cells.
At the same time the antibodies against different 
parts of non-phosphorylated mTOR molecule 
showed diffuse staining in the cytoplasm of mitotic 
cells (Fig. 2). Namely the antibodies against 
N-terminal, C-terminal regions and central part of 
mTOR molecule were applied. No convincing reac-
tion among the arms of condensed chromosomes 
was revealed. Only after chromosomes separation in 
anaphase, a bright positive reaction on mTOR was 
detected (data not shown). Phosphorylation of 
mTOR on Ser2481 could change the conformation 
of molecule that will make phospho-mTOR 
(Ser2481) inaccessible for the antibodies against 
non-phosphorylated mTOR. 
Discussion
Serine 2481 is one of four characterized phospho-
sites of mTOR kinase. It is known to be autophos-
phorylated by mTOR. Serine 2481 localizes at the 
regulatory domain of the kinase and could be in-
volved in the modulation of its activity [8, 9]. 
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Fig. 1. A – Immunofluorescent detection of phospho-mTOR (Ser2481) (red) and Ki-67 antigen (green) in HepG2 cells.  
B – Immunofluorescent detection of phospho-mTOR (Ser2481) (red) and Ki-67 antigen (green) in metaphase plates of 
HepG2 cells.  
C – Immunofluorescent detection of phospho-mTOR (Ser2481) (red) and Ki-67 antigen (green) in metaphase plates of 
MCF-7 cells.  
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Fig. 1. A – Immunofluorescent detection of phospho-mTOR (Ser2481) (red) and Ki-67 antigen (green) in HepG2 cells. B – Immu-
nofluorescent detection of phospho-mTOR (Ser2481) (red) and Ki-67 antigen (green) in metaphase plates of HepG2 cells. C – Im-
munofluorescent detection of phospho-mTOR (Ser2481) (red) and Ki-67 antigen (green) in metaphase plates of MCF-7 cells. Cells 
in the metaphase are pointed with long arrows, the cleavage furrow in telophase are [is] pointed with small arrow. 
In mammalian cells mTOR exists as a core en-
zyme of two different complexes: mTORC1 and 
mTORC2 [13, 14, 15]. Earlier studies showed that 
specific mTOR inhibitor rapamycin treatment did 
not affect Serine 2481 phosphorilation. So, it was 
hypothesized that phospho-mTOR (Ser2481) is a 
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unique feature of mTORC2 [16]. However, further 
investigations demonstrated that the growth factors 
such as insulin stimulate the autophosphorylation of 
mTOR associated with both mTORC1 and mTORC2. 
Also, it was revealed that phosphorylation of Ser 
2481 in both complexes was sensitive to wortman-
nin, a phosphatidylinositol 3-kinase (PI3K) inhibi-
tor. This finding indicates that insulin promotes 
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Fig.2.  Immunofluorescent detection of mTOR kinase in proliferating MCF-7 cells. 
A - antibodies against central region of  mTOR molecule (clone F11, Merck Millipore), 
B - antibodies against  C terminal part of mTOR (7C10, Cell Signaling), 
C - antibodies against N-terminus of mTOR kinase (N19, Santa Cruz). 
DNA was counterstained with Hoechst 33342.  Cells in the metaphase are pointed with arrows. 
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Fig.2.  Immunofluorescent detection of mTOR kinase in proliferating MCF-7 cells. 
A - antibodies against central region of  mTOR molecule (clone F11, Merck Millipore), 
B - antibodies against  C terminal part of mTOR (7C10, Cell Signaling), 
C - antibodies against N-terminus of mTOR kinase (N19, Santa Cruz). 
DNA was counterstained with Hoechst 33342.  Cells in the metaphase are pointed with arrows. 
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Fig.2.  Immunofluorescent detection of mTOR kinase in proliferating MCF-7 cells. 
A - antibodies against central region of  mTOR molecule (clone F11, Merck Millipore), 
B - antibodies against  C terminal part of mTOR (7C10, Cell Signaling), 
C - antibodies against N-terminus of mTOR kinase (N19, Santa Cruz). 
DNA was counterstained with Hoechst 33342.  Cells in the metaphase are pointed with arrows. 
Fig. 2. Immunofluorescent detection of mTOR kinase in proliferating MCF-7 cells. A – antibodies against central region of mTOR 
molecule (clone F11, Merck Millipore), B – antibodies against C terminal part of mTOR (7C10, Cell Signaling Technology), C – 
antibodies a ainst N-termin s of mTOR kinase (N19, Santa Cruz Biotechnology). DNA was counterstained with Hoechst 33342. 
Cells in the metaphase are pointed with a rows. 
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Ser2481 autophosphorylation in both complexes - 
mTORC1 and mTORC2 [17].
Our immunofluorescent analysis revealed that 
mTOR phosphorylated at Ser2481 localized at the 
specific compartments of the mitotic cells and con-
centrated to the midzone and midbody during ana-
phase and telophase. The previous data showed that 
at cytokinesis mTOR, phosphorylated at Ser2481, 
appeared as a doublet at the apical ends of two 
daughter cells [10]. These data suggest that phospho-
mTOR (Ser2481) could play an important but yet 
unknown role in mitosis and cytokinesis regulation. 
The recent studies have shown that phospho-
mTOR (Ser2481) co-localizes with chromosomal 
passenger proteins (CPPs) during cell cytokinesis 
[11]. It was revealed that phospho-mTOR (Ser2481) 
and CPPs INCENP and Aurora B overlaped during 
anaphase, telophase and cytokinesis. Therefore, it 
was hypothesized that phosphorylated mTOR may 
behave as a CPP-like protein at the spindle midzone 
and at the cleavage furrow [11]. Our findings strong-
ly support this hypothesis. We also detected mTOR 
at the midbody and the cleavage furrow, but unlike 
the above data we demonstrated for the first time that 
phospho-mTOR (Ser2481) localized at the chromo-
somes of the metaphase plate in mitotic MCF-7 and 
HepG2 cells. The differences between our studies 
and previous work could be explained by possible 
discrepancies of the immunostaining protocols and 
technique of image acquisition.
It is known that CPPs localizes initially along 
chromosome arms, but progressively concentrates at 
inner centromeres through prometaphase and meta-
phase. There they regulate the chromosome structure 
and correction of kinetochore–microtubule attach-
ment [18]. The discovered phospho-mTOR 
(Ser2481) localization at the metaphase plate shows 
the pattern similar to CPPs, but the real role and 
function of Ser2481 phosphorylation during mitosis 
are still unknown. It suggests that it participates in 
the formation of a niche for future midbody. From 
the other hand, our finding also raises a question 
about phospho-mTOR (Ser2481) co-localization 
with centromere proteins and its possible participa-
tion in the chromosomal passenger complex func-
tioning.
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Phospho-mTOR (Ser2481) співлокалізується 
з конденсованими хромосомами під час метафази
В. Р. Косач, І. О. Тихонкова, О. В. Чередник, 
В. В. Філоненко, А. І. Хоруженко
Мета. Дослідити внутрішньоклітинну локалізацію phospho-
mTOR (Ser2481) в лініях ракових клітин людини. Методи. 
Подвійний імунофлуоресцентний аналіз. Культивовані кліти-
ни ліній MCF-7 (аденокарцинома молочної залози людини) і 
HepG2 (карцинома печінки людини). Результати. Вперше 
phospho-mTOR (Ser2481) був виявлений у вигляді яскравих то-
чок, які розташовувались в екваторіальній області клітини та 
співлокалізувались з конденсованими хромосомами під час 
метафази. Висновки. У цьому дослідженні ми вперше описує-
мо співлокалізацію phospho-mTOR (Ser2481) і хромосом мета-
фазної пластинки у клітинах ліній MCF-7 і HepG2. Наші дані 
підкріплюють гіпотезу, що phospho-mTOR (Ser2481) може ви-
ступати в якості СРР-кінази і брати участь у регуляції прохо-
дження мітозу.
К л юч ов і  с л ов а: mTOR, phospho-mTOR (Ser2481), мітоз, 
фосфорилювання mTOR, метафаза.
Phospho-mTOR (Ser2481) колокализируется 
с конденсированными хромосомами в метафазе
В. Р. Косач, И. А. Тихонкова, О. В. Чередник, 
В. В. Филоненко, А. И. Хоруженко
Цель. Исследовать внутриклеточную локализацию phospho-
mTOR (Ser2481) в раковых клеточных линиях человека. 
Методы. Двойной иммунофлуоресцентный анализ. Культи-
ви ро ванные клетки линий MCF-7 (аденокарцинома молоч-
ной железы человека) и HepG2 (карцинома печени человека). 
Результаты. Впервые phospho-mTOR (Ser2481) был обнару-
жен в виде ярких точек, которые располагались в экватори-
альной области клетки и колокализировались с конденсиро-
ванными хромосомами во время метафазы. Выводы. В этом 
исследовании мы впервые описываем колокализацию 
phospho-mTOR (Ser2481) и хромосом метафазной пластинки 
в клетках линий MCF-7 и HepG2. Наши данные подкрепляют 
гипотезу, что phospho-mTOR (Ser2481) может выступать в ка-
честве СРР-киназы и участвовать в регуляции прохождения 
митоза.
К л юч е в ы е  с л ов а: mTOR , phospho-mTOR (Ser2481), ми-
тоз, фосфорилирование mTOR, метафаза. 
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